Jeff Adams has been received a 4-year suspension after failing an in-competition drug test at the 2022 CrossFit Games. Adams, who competed in the Men’s 50-54 age group division at the Games, finished 5th overall. However, after taking a drug test it was revealed that his sample contained S-23.
From what we can tell CrossFit never made an official announcement about Adams’ failed drug test and subsequent sanction. Back on November 2, 2022, CrossFit did tell The Barbell Spin that one athlete was still appealing the results of their drug test, but no other details were provided.
However, since that communication there have not been any official announcements regarding Adams’ failed drug test.
Now, after six months (or at least when we found out) it appears that Adams’ appeal is over and the Masters athlete from Canada has received a 4-year sanction that runs through August 6, 2026. The only mention of Jeff Adams’ failed drug test is on the CrossFit Games’ list of all athletes currently serving sanctions.
While it is unclear when Adams’ was notified of the final ruling by CrossFit, Adams is currently on the 2023 CrossFit Open leaderboard. He is in 98th place overall after the first two weeks of the Open. He has uploaded videos for both weeks, although the video from 23.2A & B is not viewable.
Here is the video to his 23.1 Open workout:
Who is Jeff Adams?
Jeff Adams is a Masters athlete who has been competing in the CrossFit Open since 2018 when he was in the Men’s 45-49 age group division. Last year he made it to the Age Group Semifinals where he finished 7th to qualify for his first appearance at the CrossFit Games.
According to his Games profile, he is an Unaffiliate athlete although it appears he has worked out at CrossFit Estrie in Saint-Alphonse-de-Granby, QC, Canada, in the past.
While there is not much out there regarding Adams, we did find an article about Adams’ qualification to the 2022 CrossFit Games in a local newspaper.
What is S-23?
The substance that Adams had in his system was S23 SARM, or S-23 for short. It is a nonsteroidal SARM, or selective androgen receptor modulator. According to crazybulk.com, users claim it is the most potent SARM available, even more powerful than S4 Andarine.
S-23 selectively binds to the androgen receptors in bones and muscles, thereby stimulating new muscle cells and bone tissues by “mimicking” testosterone. It is also considered by many to be very dangerous in that a pharmaceutical company is researching whether it can be used as a male contraceptive.
However, at this time S-23 has never been tested on people and is not approved for human use. It, along with all SARMs, has been banned by WADA.